FR3076713B1 - Utilisation d'hemoglobine d'annelides comme bactericide, notamment pour prevenir et/ou traiter une maladie parodontale - Google Patents

Utilisation d'hemoglobine d'annelides comme bactericide, notamment pour prevenir et/ou traiter une maladie parodontale Download PDF

Info

Publication number
FR3076713B1
FR3076713B1 FR1850365A FR1850365A FR3076713B1 FR 3076713 B1 FR3076713 B1 FR 3076713B1 FR 1850365 A FR1850365 A FR 1850365A FR 1850365 A FR1850365 A FR 1850365A FR 3076713 B1 FR3076713 B1 FR 3076713B1
Authority
FR
France
Prior art keywords
bactericide
periodontal disease
prevention
treatment
hemoglobin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1850365A
Other languages
English (en)
Other versions
FR3076713A1 (fr
Inventor
Franck Zal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hemarina SA
Original Assignee
Hemarina SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemarina SA filed Critical Hemarina SA
Priority to FR1850365A priority Critical patent/FR3076713B1/fr
Priority to MX2020007550A priority patent/MX2020007550A/es
Priority to EP19700717.2A priority patent/EP3740230A1/fr
Priority to US16/962,906 priority patent/US20210060136A1/en
Priority to PCT/EP2019/051076 priority patent/WO2019141744A1/fr
Publication of FR3076713A1 publication Critical patent/FR3076713A1/fr
Application granted granted Critical
Publication of FR3076713B1 publication Critical patent/FR3076713B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne l'utilisation d'une molécule choisie parmi une globine, un protomère de globine ou une hémoglobine extracellulaire d'Annélides, comme bactéricide, notamment pour prévenir et/ou traiter une maladie parodontale.
FR1850365A 2018-01-17 2018-01-17 Utilisation d'hemoglobine d'annelides comme bactericide, notamment pour prevenir et/ou traiter une maladie parodontale Active FR3076713B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR1850365A FR3076713B1 (fr) 2018-01-17 2018-01-17 Utilisation d'hemoglobine d'annelides comme bactericide, notamment pour prevenir et/ou traiter une maladie parodontale
MX2020007550A MX2020007550A (es) 2018-01-17 2019-01-16 Uso de hemoglobina de anelidos como bactericida, en particular para prevenir y/o tratar una patologia periodontal.
EP19700717.2A EP3740230A1 (fr) 2018-01-17 2019-01-16 Utilisation d'hémoglobine d'annélides comme bactéricide, notamment pour prévenir et/ou traiter une maladie parodontale
US16/962,906 US20210060136A1 (en) 2018-01-17 2019-01-16 Use of hemoglobin from annelids as bactericide, in particular for preventing and/or treating a periodontal disease
PCT/EP2019/051076 WO2019141744A1 (fr) 2018-01-17 2019-01-16 Utilisation d'hémoglobine d'annélides comme bactéricide, notamment pour prévenir et/ou traiter une maladie parodontale

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1850365A FR3076713B1 (fr) 2018-01-17 2018-01-17 Utilisation d'hemoglobine d'annelides comme bactericide, notamment pour prevenir et/ou traiter une maladie parodontale
FR1850365 2018-01-17

Publications (2)

Publication Number Publication Date
FR3076713A1 FR3076713A1 (fr) 2019-07-19
FR3076713B1 true FR3076713B1 (fr) 2020-12-25

Family

ID=62222820

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1850365A Active FR3076713B1 (fr) 2018-01-17 2018-01-17 Utilisation d'hemoglobine d'annelides comme bactericide, notamment pour prevenir et/ou traiter une maladie parodontale

Country Status (5)

Country Link
US (1) US20210060136A1 (fr)
EP (1) EP3740230A1 (fr)
FR (1) FR3076713B1 (fr)
MX (1) MX2020007550A (fr)
WO (1) WO2019141744A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
FR3120521B1 (fr) * 2021-03-15 2024-03-29 Hemarina Gel à base d’hémoglobine d’Annélides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050106111A1 (en) * 2003-09-16 2005-05-19 Aphios Corporation Compositions and methods for reducing dental plaque
FR2917292B1 (fr) * 2007-06-18 2014-06-13 Centre Nat Rech Scient Utilisation d'une hemoglobine pour la preparation de pansements, et pansements ainsi prepares
FR2920666B1 (fr) * 2007-09-11 2010-11-26 Khorionyx Preparations implantables contenant de la globine, procede pour leur fabrication et utilisations
FR2975869B1 (fr) * 2011-05-31 2017-03-03 Hemarina Composition de preservation d'organe et utilisations

Also Published As

Publication number Publication date
EP3740230A1 (fr) 2020-11-25
US20210060136A1 (en) 2021-03-04
MX2020007550A (es) 2020-10-28
WO2019141744A1 (fr) 2019-07-25
FR3076713A1 (fr) 2019-07-19

Similar Documents

Publication Publication Date Title
EA200801481A1 (ru) 5-(арилсульфонил)пиразолопиперидины
MA43763A (fr) Protéine f de pré-fusion du vrs soluble et stabilisée pour son utilisation dans la prophylaxie d'une infection vrs
MA44851B1 (fr) Dérivés pyridinyltriazole substitués par des groupements amides et leurs utilisations
PH12020500257A1 (en) Quinoline derivatives for treating infections with helminths
ATE254461T1 (de) Behandlung von augenschmerzen
MA40893B1 (fr) Dérivés de phényltriazole à substitution hydroxyalkyle et utilisations associées
EP1951251A4 (fr) Antagonistes du recepteur cgrp de spirohydatoin aryle
NO20063275L (no) Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom
FR2938437B1 (fr) Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
EP1673078A4 (fr) Inhibiteurs de type benzylether et benzylamino de beta-secretase pour le traitement de la maladie d'alzheimer
FR2856294B1 (fr) Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
NZ759633A (en) New azaquinoline derivatives
PH12020551891A1 (en) New quinoline derivatives
FR3076713B1 (fr) Utilisation d'hemoglobine d'annelides comme bactericide, notamment pour prevenir et/ou traiter une maladie parodontale
ATE489948T1 (de) Behandlung von autoimmunkrankheiten
ES2119185T3 (es) Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad.
EA202190888A1 (ru) Пептид для применения в косметике
MA38369B1 (fr) Peptides et compositions pour le traitement d'une lesion de l'articulation
EA200400436A1 (ru) Медикаменты для профилактики и лечения бромидроза
ATE432936T1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
FR3008316B1 (fr) Utilisation de fibroblastes gingivaux dans le traitement de l'alopecie
MX2022000433A (es) Proteinas de fusion a toxina para el tratamiento de enfermedades relacionadas con infecciones por cmv.
FR3092998B1 (fr) Composition cosmétique à base de produit végétal
FR3108842B1 (fr) Utilisation d'hémoglobine d'Annélides pour traiter le syndrome de détresse respiratoire aiguë
FR3062796B1 (fr) Utilisation d'un compose appartenant a la famillle des diuretiques pour traiter le cancer

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20190719

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7